Search Results (502)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Analysis of Drosophila segmentation network identifies a JNK pathway factor overexpressed in kidney cancer. | Academic Article |
Why?
|
| Angiogenesis inhibition in non-clear cell renal cancer. | Academic Article |
Why?
|
| Bevacizumab and everolimus in renal cancer: a rational way forward. | Academic Article |
Why?
|
| Chromosomes, hypoxia, angiogenesis, and trial design: a brief history of renal cancer drug development. | Academic Article |
Why?
|
| Cytokine therapy in metastatic renal cancer. | Academic Article |
Why?
|
| Effective therapy for metastatic renal cancer, whither to now. | Academic Article |
Why?
|
| Emerging targets in kidney cancer: opportunities for drug development. | Academic Article |
Why?
|
| Gene expression profiling in kidney cancer: combining differential expression and chromosomal and pathway analyses. | Academic Article |
Why?
|
| Genetic basis of kidney cancer: a model for developing molecular-targeted therapies. | Academic Article |
Why?
|
| Human renal cancer carcinogenesis: a review of recent advances. | Academic Article |
Why?
|
| Innovations and challenges in renal cancer: consensus statement from the first international conference. | Academic Article |
Why?
|
| Kidney cancer. | Academic Article |
Why?
|
| Local progression after operative treatment of metastatic kidney cancer. | Academic Article |
Why?
|
| Melanotic Xp11 translocation renal cancer: report of a case with a unique intratumoral sarcoid-like reaction. | Academic Article |
Why?
|
| Obscenity, Michael Jordan, and Measuring Outcomes: Explaining and Improving the Quality of Kidney Cancer Care. | Academic Article |
Why?
|